#COVID19SA #Biomarkers, Chemical Pathology Division Head at Stellenbosch University, Prof Annalise Zemlin, says medical researchers are studying which patients being treated for COVID-19 are at a higher risk for severe illness. KB Image : Damien Schumann. 
Zemlin “hopefully the findings of the study will show how the levels of the biomarkers or the changes in levels of biomarkers over time,can predict which patients will have a more serious disease progression and possibly allow us to intervene earlier and prevent this progression”
#COVID19SA The research study will identify biochemical, haematological and immunological biomarkers including novel ones not routinely tested but possibly associated with increased risk of severe illness. KB
#COVID19 “These include, but are not limited to, inflammatory cytokines, markers of vascular endothelial damage and novel miRNA markers. Identification of these biomarkers will likely aid development of more personalised, Covid-19 directed therapeutic approaches. “ KB
#COVID19SA The collaborative project involves SU, Nairobi University, CPUT, the University of Limpopo and University College London, and has received a two-year, US $100 000 grant from the Covid-19 Africa Rapid Grant Fund. KB
#COVID19 “The study will initially test samples from patients at three hospitals - Tygerberg Hospital, Kenyatta National Hospital and Pietersburg Hospital in Limpopo”. KB
• • •
Missing some Tweet in this thread? You can try to
force a refresh
